Clinical Trial

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore the effectiveness of 18F-G1 PET/CT in patients with solid tumors and hematological malignancies receiving immunotherapy
Trial Details
NCT Number NCT07039474
Lead Sponsor Peking University First Hospital
Conditions Solid Tumors and Hematological Tumors
Enrollment 120 participants
Start Date 2025-07-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-26